SIG Brokerage’s Vertex Pharmaceuticals VRTX Stock Holding History

SIG Brokerage’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,500	Closed	-$4.31M	–	988
2025 Q4	$4.31M	Sell	9,500 -5,600	-37%	-$2.41M	0.13%	128
2025 Q3	$5.91M	Buy	15,100 +7,600	+101%	+$3.18M	0.17%	110
2025 Q2	$3.34M	Hold	7,500	–	–	0.09%	158
2025 Q1	$3.64M	Hold	7,500	–	–	0.18%	96
2024 Q4	$3.02M	Buy	+7,500	New	+$3.48M	0.16%	94

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

SIG Brokerage's VRTX Position: Q2 2026 in Review

SIG Brokerage increased its Vertex Pharmaceuticals (VRTX) stake by 27% in Q2 2026, buying an estimated $2.12M and bringing the position to 22,390 shares worth $11.1M. The position accounts for 0.22% of the portfolio, ranked #85.

SIG Brokerage first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.5M in Q2 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

SIG Brokerage held 22,390 shares of Vertex Pharmaceuticals worth $11.1M as of Q2 2026.
SIG Brokerage bought 4,785 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.12M.
Vertex Pharmaceuticals made up 0.22% of SIG Brokerage's portfolio in Q2 2026, its #85 holding.
SIG Brokerage first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
SIG Brokerage's Vertex Pharmaceuticals position peaked at $14.5M in Q2 2025.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.